Cystic Fibrosis Channel
Topics & Medications
Quicklinks
Related Channels

Kalydeco and Cystic Fibrosis

Approved as a treatment for cystic fibrosis, Kalydeco™ (ivacaftor) has been shown to improve lung function, reduce symptoms, and boost weight gain. Also, people who used this prescription medication during clinical trials had a reduced chance of pulmonary exacerbations. Kalydeco is approved for use in adults and children as young as six years old.
 
Kalydeco is prescribed for cystic fibrosis treatment in people with certain mutations, including G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R.
 
(Click Kalydeco Uses to learn more about using this drug to treat cystic fibrosis. This Web page offers detailed information on how Kalydeco works and other topics.)
6 Quick Tips for Getting Kids to Take Medicine
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.